Filtern
Volltext vorhanden
- ja (10)
Gehört zur Bibliographie
- ja (10)
Dokumenttyp
Sprache
- Englisch (10)
Schlagworte
- amplicon sequencing (2)
- apoptosis (2)
- multiple myeloma (2)
- AKT-signaling (1)
- Activation (1)
- BCL2 (1)
- CYP24A1 (1)
- Cushings syndrome (1)
- Fak regulation (1)
- Immunoreceptors (1)
- Immunrezeptoren (1)
- Induced apoptosis (1)
- KRAS (1)
- Keimzentrum (1)
- MEK/ERK-signaling (1)
- MYC (1)
- Mechanisms (1)
- Medizin (1)
- Migration (1)
- Multiple (1)
- Multiple Myeloma (1)
- NF-Kappa-B (1)
- Non Hodgkin Lymphoma (1)
- Non Hodgkin Lymphome (1)
- Pathogenesis (1)
- Phase- (1)
- Stromal cells (1)
- VDR (1)
- adenomas (1)
- bone metastasis (1)
- breast cancer (1)
- cancer detection (1)
- cancer diagnosis (1)
- carcinogenesis (1)
- carcinoma (1)
- carcinomas (1)
- catenin (1)
- cell-cycle arrest (1)
- chromosomes (1)
- comparative genomic hybridization (1)
- consensus DNA (1)
- damage (1)
- expression (1)
- gene expression (1)
- genetic loci (1)
- glutaminase inhibition (1)
- high-resolution analysis (1)
- human genome (1)
- in-vivo (1)
- kinase (1)
- malignant tumors (1)
- network (1)
- neutral loss (1)
- notch signaling (1)
- rare SNP (1)
- receptor tyrosine kinases (1)
- serum (1)
- transcriptional repression (1)
- tumors (1)
- vitamin D (1)
- vitamin D receptor (1)
Institut
Sonstige beteiligte Institutionen
Active vitamin D (1,25(OH)2D3) is known to exert direct anti-cancer actions on various malignant tissues through binding to the vitamin D receptor (VDR). These effects have been demonstrated in breast, prostate, renal and thyroid cancers, which all have a high propensity to metastasise to bone. In addition, there is evidence that vitamin D catabolism via 24-hydroxylase (CYP24A1) is altered in tumour cells, thus, reducing local active vitamin D levels in cancer cells. The aim of this study was to assess VDR and CYP24A1 expression in various types of bone metastases by using immunohistochemistry. Overall, a high total VDR protein expression was detected in 59% of cases (39/66). There was a non-significant trend of high-grade tumours towards the low nuclear VDR expression (p = 0.07). Notably, patients with further distant metastases had a reduced nuclear VDR expression (p = 0.03). Furthermore, a high CYP24A1 expression was detected in 59% (39/66) of bone metastases. There was a significant positive correlation between nuclear VDR and CYP24A1 expression (p = 0.001). Collectively, the VDR and CYP24A1 were widely expressed in a multitude of bone metastases, pointing to a potential role of vitamin D signalling in cancer progression. This is of high clinical relevance, as vitamin D deficiency is frequent in patients with bone metastases.